CD4 and neoplasm: However, recent studies have shown that the increased expression of endogenous TLR3 in tumor cells can improve the responses of CD4+ Th1 and CD8+ cytotoxic T cells (37, 38), and is used to improve immunotherapy by innate immunity in the TMEt (39, 40).